시장보고서
상품코드
2077308

맞춤형 재조합 단백질 생산 서비스 시장 : 발현 시스템별, 최종사용자별, 지역별

Custom Recombinant Protein Production Services Market, By Expression System, By End User, By Region

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,704,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,428,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 14,898,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

커스텀 재조합 단백질 생산 서비스 시장은 2026년에 68억 달러 규모에 달할 것으로 추정되며, 2033년까지 147억 6,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 11.7%로 성장할 것으로 전망됩니다.

보고서 범위 보고서 상세
기준 연도: 2025년 2026년 시장 규모: 68억 달러
과거 데이터 기간: 2020-2024년 예측 기간: 2026-2033년
2026년부터 2033년까지 예측 기간의 CAGR: 11.70% 2033년 시장 규모 예측: 147억 6,000만 달러

맞춤형 재조합 단백질 생산은 생명과학 분야에서 활용되는 효율적인 기술 중 하나이며, 첨단 헬스케어 분야에서 중요한 역할을 하고 있습니다. 재조합 단백질은 생명공학, 연구, 의료 분야에서 폭넓게 활용되고 있습니다. 생명과학 분야에 대한 자금 투자가 증가함에 따라, 맞춤형 재조합 단백질 생산 서비스 시장의 성장이 가속화될 것으로 예상됩니다. 치료 분야에서 재조합 단백질의 중요성은 비약적으로 높아지고 있습니다. 많은 바이오의약품 기업들이 생명을 위협하는 질환에 대한 새로운 바이오시밀러의 연구 개발에 주력하고 있습니다. 단백질은 특정 기술을 이용하여 조작되어, 재조합 단백질이 생성됩니다. 이러한 재조합 단백질은 대량의 단백질을 생산하기 위해 유전자에 의해 암호화되어 있습니다. 재조합 단백질은 또한 치료용 시판 제품의 제조에도 활용되고 있습니다. 재조합 단백질 생산 기술의 발전이 시장 성장을 견인할 것으로 전망됩니다.

시장 역학

생명과학 분야에 대한 자금 지원 및 투자의 증가가 예측 기간 동안 시장 성장을 견인할 것으로 전망됩니다. 예를 들어, 옥스퍼드 단백질 생산 시설(영국)은 분자생물학 연구소로부터 300만 달러의 추가 자금을 지원받았습니다. 이는 재조합 단백질의 고처리량 정제, 발현, 결정화를 위한 로봇 시스템을 통합하여, 광범위하고 고도로 전문화된 기술을 제공하기 위한 것입니다.

본 조사의 주요 특징:

  • 본 보고서는 맞춤형 재조합 단백질 생산 서비스 시장에 대한 상세한 분석을 제공하는 한편, 2025년을 기준 연도로 하여 2026년부터 2033년까지의 예측 기간 동안의 시장 규모 및 연평균 성장률(CAGR)을 제시하고 있습니다.
  • 본 보고서에서는 다양한 부문의 잠재적 수익 기회를 파악하는 한편, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
  • 또한, 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
  • 본 보고서에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 맞춤형 재조합 단백질 생산 서비스 시장의 주요 업체들을 분석하고 있습니다.
  • 이 보고서에서 얻을 수 있는 인사이트는 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내리는 데 도움이 됩니다.
  • 본 '맞춤형 재조합 단백질 생산 서비스 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자 여러분은 맞춤형 재조합 단백질 생산 서비스 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.

목차

제1장 조사 목적과 가정

제2장 시장 전망

제3장 시장 역학·규제·동향 분석

제4장 세계의 맞춤형 재조합 단백질 생산 서비스 시장 : 발현계별, 2021-2033년

제5장 세계의 맞춤형 재조합 단백질 생산 서비스 시장 : 최종사용자별, 2021-2033년

제6장 세계의 맞춤형 재조합 단백질 생산 서비스 시장 : 지역별, 2021-2033년

제7장 경쟁 구도

제8장 섹션

KSM 26.07.08

Custom Recombinant Protein Production Services Market is estimated to be valued at USD 6.80 Bn in 2026 and is expected to reach USD 14.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6.80 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 11.70% 2033 Value Projection: USD 14.76 Bn

Custom recombinant protein production is one of the efficient techniques used in life sciences that play a major role in advanced healthcare. Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Increasing funding in the field of life sciences is expected to accelerate growth of the custom recombinant protein production services market. The importance of recombinant protein for therapeutic application is increasing immensely. Various biopharmaceutical companies are focusing on research and development of novel biosimilars for life threatening diseases. Proteins are manipulated using specified techniques to derive recombinant proteins, these recombinant proteins are encoded by genes for the production of large quantities of protein. Recombinant proteins are further used for the manufacturing of therapeutic commercial products. Technological advancement in the production of recombinant protein is predicted to boost growth of the market.

Market Dynamics

Increasing funding and investments in the field of life sciences are expected to drive the market growth during the forecast period. For instance, additional funding of US$ 3.0 million was received by Oxford Protein Production Facility-UK from the Laboratory of Molecular Biology for providing a wide range of highly specialized technologies that incorporates robotic systems for high throughput purification, expression, and crystallization of recombinant proteins.

Key features of the study:

  • The report provides an in-depth analysis of the Custom Recombinant Protein Production Services market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2026-2033, considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the custom recombinant protein production services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the custom recombinant protein production services market

Detailed Segmentation:

  • Custom Recombinant Protein Production Services Market, By Expression System (Revenue, USD Bn, 2021 - 2033)
  • Mammalian
  • Bacteria
  • Insect
  • Yeast
  • Others
  • Custom Recombinant Protein Production Services Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organizations
  • Others
  • Custom Recombinant Protein Production Services Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • By Expression System
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
    • , By End User
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Expression System
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
    • , By End User
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Expression System
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
    • , By End User
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Expression System
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Other
    • By End User
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Expression System
      • Mammalia
      • Bacteria
      • Insect
      • Yeast
      • Others
    • , By End User
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Expression System
      • Mammalian
      • Bacteria
      • Insect
      • Yeast
      • Others
    • , By End User
      • Research Institutes
      • Biotechnology and Pharmaceutical Companies
      • Contract Research Organizations
      • Others
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • GenScript Biotech Corporation *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SignalChem Biotech Inc.
  • Crown Bioscience, Inc.
  • BPS Bioscience Inc.
  • Novoprotein
  • Applied Biological Materials (abm) Inc.
  • Eurofins Pharma Discovery Services
  • Abgent (WuXi AppTec Company)
  • OriGene Technologies, Inc.
  • Kempbio, Inc.,
  • Trenzyme GmbH
  • Sino Biological Inc.
  • Aragen Bioscience, a GVKBIO Company
  • LakePharma, Inc.
  • Proteos, Inc.
  • Icosagen AS
  • Novous Biologicals LLC
  • Proteogenix
  • Premas Biotech
  • ATUM
  • Aldevron

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Expression System
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Custom Recombinant Protein Production Services Market, By Expression System , 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Mammalian
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Bacteria
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Insect
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Yeast
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends

5. Global Custom Recombinant Protein Production Services Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends

6. Global Custom Recombinant Protein Production Services Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Expression System , 2021 -2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 -2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Company Profiles
    • GenScript Biotech Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • SignalChem Biotech Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Crown Bioscience, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • BPS Bioscience Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Novoprotein
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Applied Biological Materials (abm) Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Eurofins Pharma Discovery Services
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Abgent (WuXi AppTec Company)
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Kempbio, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Trenzyme GmbH
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Sino Biological Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Aragen Bioscience, a GVKBIO Company
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • LakePharma, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Proteos Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Icosagen AS
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Novus Biological LLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Proteogenix
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Premas Biotech
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • ATUM
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Aldevron
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Contact
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기